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ABSTRACT 
Epidemiologic studies demonstrate that alcohol is the most prevalent teratogen to 
which humans are exposed. In the US, it is estimated that at least one percent of children 
suffer from fetal alcohol spectrum disorder (FASD) or alcohol-related birth defects 
associated with Fetal Alcohol Syndrome (FAS). FAS is associated with facial 
abnormalities, cognitive impairment, behavioral problems, and decreased birth weight. 
Over the past 40 years, clinical studies have reported multiple instances where infants 
were born with characteristic FAS symptoms to mothers who had not consumed alcohol 
during pregnancy; but whose fathers were either heavy drinkers or chronic alcoholics. 
These studies indicate that the father’s lifestyle may be an unrecognized element in the 
genesis of this disorder. Studies of a wide-range of environmental exposures have 
demonstrated that changes in the male-inherited epigenetic program profoundly 
influence offspring development and health. Given that 70% of men drink and 40% 
drink heavily, we hypothesize that errors in the male-inherited developmental program 
drive several key FAS-associated birth defects.  
We examined how chronic preconception male alcohol exposure impacts fetal 
growth and development. We employed a mouse model that allowed us to quantitatively 
track parental patterns of inheritance. B6(Cast7) males were chronically exposed 10% 
ethanol for a period of 70 days, and then mated with non-exposed C57BL/6J dams. Our 
studies identified a significant decrease in the weight of the gestational sac and fetus, as 
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well as a decrease in crown rump length. While placental weights were identical 
between the treatment groups, we did identify a significant increase in the relative 
placental weight of offspring sired by alcohol exposed males. In addition, we found that 
many of the growth defects exhibited a female sex-specific patterns of inheritance with 
three parameters that were measured. Molecular analysis of of multiple candidate 
imprinted genes identified alteration in the expression of H19, Cdkn1c, Dio3 and Mirg. 
Of these, Dio3 displayed a sex-specific effect, where treated females exhibited increased 
expression compared to control females as well as male offspring from treated males. 
Collectively, our studies suggest that chronic preconception male alcohol exposure is 
associated with fetal growth restriction, a well-characterized FAS-associated birth 
defect. 
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CHAPTER I  
INTRODUCTION AND LITERATURE REVIEW 
1.1 Epigenetics 
1.1.1 The History of Epigenetics 
Epigenetics is the study of heritable changes in gene expression and cellular 
phenotypes that occur through modifications to the genome caused by environmental 
factors, but which do not change the underlying DNA sequence.  The term epigenetics 
stems from the Greek word “epi”, meaning above, therefore, epigenetics is said to be 
above genetics.  This field of epigenetics originated by observing inheritance patterns 
which contradicted Mendelian genetics, such as variation in embryo growth, twins, and 
plants [1] (Figure 1). 
Figure 1. Examples of Epigenetic Phenotypes. Twins, silenced X chromosome, polytene chromosome, 
yeast mating types, blood smear, tumor tissue, mutant plant, and cloned cat. [1] 
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The study of epigenetics seeks to understand how zygotes develop into an 
organism with specific phenotypes. There are several questions scientists are studying. 
Among these are: How could the phenotype change without the change of underlying 
nucleic acids [2]? What controls genes being expressed while others are silent? How 
does the environment play a role in phenotypic expression? 
 The first studies of epigenetics were performed by H.J. Muller using X-rays and 
the Drosophila model. He found a class of alleles that had a high rate of phenotypic 
change which he called “eversporting displacements”. The most prominent phenotypic 
change was in the eyes, where he noticed their eyes had a mosaic patterning: “even if all 
the parts of the chromatin appeared to be represented in the right dosage - though 
abnormally arranged” [3]. 
Additionally, in 1951 Barbara McClintock, discovered that “controlling 
elements” were the cause of the different physical characteristics in maize [4]. 
McClintock identified two genetic loci that were dominant in determining the kernel 
colors in maize, Dissociator (Ds) and Activator (Ac). She discovered that these loci 
could transpose on the chromosome resulting in a mosaic color pattern (Figure 2). In the 
presence of Ac, the Ds can break away from chromosome 9. When Ds breaks away, the 
aleurone-color gene is released and the synthesis of pigment can begin resulting in the 
mosaic color pattern. 
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Figure 2. Mosaic Coloring of a Kernel. There is no Ac is present in 10 and Ds inhibits the synthesis of 
color. (11-13) One Ac is present and Ds moves to create a mosaic pattern by synthesizing pigments. (14) 
Two Ac are present (15) Three Ac are present. [4] 
 
Another study examined the inactivated X chromosome and found an epigenetic 
process [5,6]. There were no changes in the DNA sequence of the in the inactive form of 
the X chromosome, so how did the X chromosome become silenced?  Riggs 
hypothesized that the X chromosome was silenced by DNA methylation, a covalent 
modification to the DNA, a type of epigenetic mark [7]. Doskočil and Storm found an 
inheritance mechanism of this epigenetic mark through DNA replication [8]. Patterns of 
DNA methylation marks on the parent strand were copied and then passed down to the 
daughter strands (Figure 3). 
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Figure 3. Maintaining DNA Methylation. During replication one methylated strand pairs with an 
unmethylated strand. DNA methyltransferase recognizes the hemimethylated DNA and methylates the 
new strand in order to maintain the methylation pattern. [1] 
 
 
The inactivation of the X (Xi) chromosome is a random event to initiate a dosage 
compensation [6]. An X inactivation center (XIC) located on the X chromosome has a 
large non-coding RNA, X-inactive specific transcript (Xist) in cis with the chromosome 
that is responsible for the inactivation [9]. There is an upregulation of Xist RNA 
covering the X chromosome to initiate silencing [10].  Xist promotes the recruitment of 
PRC1 (polycomb repressive complex) and PRC2 which have catalytic activity towards 
chromatin structure [11].  Histone 2A Lys119 ubiquitylation (H2AK119ub1) and histone 
3 Lys27 trimethylation (H3K27me3) are mediated by PRC1 and PRC2 respectively on 
Xi [12,13]. X chromosome inactivation is associated with the methylation of H3-K27 by 
the Eed-Ezh2 complex [12,13]. 
  5 
In 1942, Conrad Waddington created the term “epigenetics”.  He described an 
“epigenetic landscape” on the basis of how the genes interact with their environment 
during development to form a specific phenotype; the end result is not completely 
determined by parental genome. The classic image that he describes is a marble rolling 
down to the lowest elevation which represents how the environmental landscape can 
influence gene expression [14] (Figure 4).  
 
 
Figure 4. Waddington’s Epigenetic Landscape. A metaphor for cellular decision making during 
development of a marble rolling downhill. [14] 
 
 
 
1.1.2. The Difference between Genetics and Epigenetics 
 
We are more than the sum of our genes [15]. 
    You can inherit something beyond the DNA sequence. That’s where the real 
excitement in genetics is now [16]. 
 
Epigenetics is reversible, stable, and plastic. In contrast, DNA is non-reversible, 
static, and heritable. It is thought that epigenetics alters transcription, dictating which 
proteins are made based on modifications to the chromatin structures (Figure 5). 
Chromatin is comprised of tightly bound DNA wrapped around eight histone protein 
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cores to form a nucleosome. Depending on how tightly the the chromatin is wrapped, it 
can form euchromatin or heterochromatin. The former resembles “beads on string” while 
the latter is very highly condensed. 
 
 
Figure 5. Genetics vs. Epigenetics. Genetics is heritable and mutations can occur (red stars). Epigenetics 
alters the chromatin structure by histone modification (mod), chromosome remodeling (remodeler), DNA 
methylation (Me), non coding RNAs (blue), and histone variant composition (yellow). [1] 
 
 
 
DNA is comprised of four nucleic bases - adenine, thymine, cytosine, and 
guanine with each base attached to a deoxyribose and a phosphate group. One of the 
most well-known epigenetic process is DNA methylation of cytosine in CpG islands that 
are in promoter rich areas. Additionally, another well-known epigenetic process is 
posttranslational modification of histone proteins [17]. 
The nucleosomes consist of an octamer with two sets of H2A, H2B, H3, and H4 
[18]. Amino acids located on the tail ends of the histone proteins can undergo 
posttranslational modification by acetylation, methylation or other covalent 
modifications. Depending on the modifications made, the structure and recruitment of 
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DNA binding proteins can loosen (euchromatin) or tighten (heterochromatin) the 
chromatin resulting in repression or activation of genes respectively [19]. 
Currently, “epigenetics [...], is at the epicenter of modern medicine because it can 
help to explain the relationship between an individual's genetic background, the 
environment, aging, and disease” [20]. Each individual has their own epigenome 
dependent on their family history and lifestyle environmental exposures such as drugs, 
diet, and exercise. All these factors need to be taken into account during treatment or 
postulating a certain condition in the medical field. As such, epigenetics is hypothesized 
to be the basis of many developmental disabilities including fetal alcohol syndrome, 
Beckwith-Wiedemann syndrome, Rhett syndrome, autism, and Fragile X syndrome 
[21,22]. The study of epigenetics will be crucial for the development of new medical 
practices and therapies. 
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1.2  Methylation 
1.2.1 Process of DNA Methylation 
DNA methylation is the first discovered heritable mechanism to influence gene 
expression [23]. DNA methylation is the addition of a methyl group (-CH3) on the fifth 
carbon of a cytosine nucleotide to form 5-methylcytosine. These modified bases are 
often found in CpG islands by a family of enzymes called DNA methyltransferases 
(DNMT) (Figure 6). The methylation groups are added to the major grooves of DNA. 
This addition affects the protein interaction in prokaryotes and is probably analogous in 
eukaryotes [23].  
 
 
Figure 6. DNA Methylation. The addition of a methyl group by DNA methyltransferase with the aid of 
S-adenosylmethionine (SAM) which is converted to S-adenosylhomocysteine. (SAH).[24] 
 
 
The genome contains many “CpG islands [that] are short, dispersed regions” of 
methylated DNA [25]. About 70% of CpG islands are methylated in the animal cell [26]. 
In 1992, Larsen identified 240 CpG islands associated with genes after analyzing a total 
of 375 genes. Almost all the identified CpG islands covered some part of exon 1; 
therefore, CpG islands were viewed as a good tool for identifying genes [25]. 
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When DNA methylation occurs, there are structure and energy signatures that 
appear in the DNA. For example, in the major groove of DNA, there is a steric change 
from the hydrophobic methyl group that affects the conformation of DNA and impacts 
the accessibility to proteins. The stability of the helices increases due to lower energy 
from the cytosine methylation, and increases the melting temperature (Tm) of the DNA. 
Also, the addition of the methyl group alters the local charge of the major groove by 
increasing electrostatic interaction with positively charged groups [27]. 
The noncoding and repetitive regions of DNA can be found by looking for CpG 
densely patterns of methylation. In higher eukaryotes, with an increase in noncoding and 
repetitive regions, there is a corresponding increase in DNA methylation. (Figure 7). 
DNA methylation protects the genome by silencing nucleic acids of exogenous origin, 
such as transposable elements (e.g. ones observed in maize by McClintock) and 
repetitive sequences [1][4]. 
 
 
Figure 7. Genome Organization Based on Organism. The non-coding (black) and repetitive DNA 
(grey) increases with increasing more complex organism. The white portion is the amount of coding genes 
in each organism.[1] 
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When DNA is methylated, proteins cannot easily access the DNA, making 
transcription difficult. Therefore, by interfering with transcription factors, DNA 
methylation is associated with transcriptional silencing [26,28]. Conversely, “active” 
genes are associated with demethylation because RNA polymerase II can easily 
transcribe DNA.  For reference, only 20-30% of genes that are expressed are methylated 
[26]. 
1.2.2 Regulation of DNA Methylation 
In mammals, the family of enzymes termed the DNA methyltransferases or 
DNMTs regulate DNA methylations. This family is composed of DNMT1, DNMT2, 
DNMT3a,  DNMT3b, and DNMT3L. DNMT1’s role is to maintain methylation [29]. Li 
showed when DNMT1 is deactivated, it resulted in a global loss of methylation, growth 
reduction, and lethality of the embryo. The mutant embryos were 1/8th the size of the 
wildtype or heterozygous embryos, and most mutant embryos had an open anterior 
neuropore and no visible forelimb buds [30].  Schaefer found that DNMT2 methylates 
several tRNAs and protects tRNA from ribonuclease cleavage [31].  When DNMT2 was 
knocked out in mice, there was a delayed endochondral ossification of the long bones, 
and a reduction of hematopoietic stem and progenitor cells at day 8 postnatal [32]. There 
are 3 homologous genes of DNMT3 - DNMT3a, DNMT3b and DNMT3L.  De novo 
methylation by DNMT3a and DNMT3b are essential for development [33]. Knockout 
DNMT3a mice were developed at term and appeared normal compared to the wild type. 
However, the knockout mice were eventually stunted and died at four weeks of age [33]. 
The second form, DNMT3b,  is associated with Immunodeficiency, Centromere 
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Instability and Facial Anomalies (ICF) syndrome in humans[34]. DNMT3b knockout 
mice did not make it to term, but observations during gestation showed there were 
several defects including growth retardation and neural tube defects[33]. Lastly, 
DNMT3L is a regulator of DNA methylation associated with genomic imprinting and 
germ cells. In knockout mice, DNMT3L, females failed to maintain maternal imprints 
and resulted in no live offspring [35]. Whereas in knockout males, spermatocytes did not 
complete meiosis and resulted in sterility [36]. DNMT3L expressed during 
gametogenesis interacts with DNMT3a and stimulates maternal methylation of Snrpn 
and Igf2r/AirI [37]. DNMT3L has no catalytic activity, but encodes a protein needed to 
stimulate DNMT3a and DNMT3b to regulate genomic imprinting [35].   
1.2.3 DNA Methylation Pathology 
Rett Syndrome is another result of misregulation of methyl binding protein. Rett 
syndrome is a neurological condition on the X chromosome. However, because methyl 
CpG binding proteins read methylation, if there is a mutation on the methyl-CpG 
binding protein 2 (MeCP2) in humans, it can lead to Rett syndrome.  MeCp2 binds to 
methylated CpG to the adjacent adenine and thymine to repress transcription.  Since 
females have an inactivated X chromosome, they will exhibit the mutant or wild type 
gene. Females affected by Rett syndrome will show neurological signs 6-18 months after 
birth.  However, males that are hemizygous for Rett syndrome will not survive [1]. 
Methylation may also be linked to cancer [1]. There are three ways DNA 
methylation is correlated with cancer: hypomethylation of the cancer genome, 
hypermethylation of tumor suppressor genes, and direct mutagenesis[38–40].  Abnormal 
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methylation on CpG islands in genes is also associated with cancer.  There are more 
hypomethylated DNA in tumors compared to non-tumor genes [41,42]. In 1988, Cooper 
and Youssoufian stated 35% of human genetic disorders were caused by point mutations 
in the CpG dinucleotides, and 90% of those were from cytosine to thymine [43]  (Figure 
8). 
 
  
Figure 8. Conversion of 5’Methylcytosine to Thymine. Through deamination 5’methylcytosine is 
converted to thymine creating a point mutation. [44] 
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1.3 Imprinting 
1.3.1 Imprinting Mechanism 
In 1984, McGrath and Solter demonstrated that both the maternal and paternal 
genomes are required to complete embryogenesis in order to produce offspring. In their 
experiment, they used two female pronuclei (biparental gynogenone) or two male 
pronuclei (biparental androgenone) to produce a diploid mouse embryo. Their results 
showed that the biparental gynogenone/androgenone diploid embryo did not complete 
embryogenesis compared to the control embryos. “While both parental sexes contribute 
equivalent nuclear information to the zygote, this genetic information is not necessarily 
functionally equivalent.” This result indicated that both the maternal and paternal 
genomes are needed during embryogenesis [45]. 
There are around 100 imprinted genes in mammals [46]. The first imprinted 
genes were discovered in 1991 and were all located in the same imprinting control 
region (ICR). The first imprinted gene discovered was Insulin-like growth factor type 2 
receptor (Igf2r), a maternally expressed gene. A deletion of this maternal allele resulted 
in death for the embryo at E15 [47]. A short time later a paternally expressed gene, 
Insulin-like growth factor 2 (Igf2) was discovered [48]. The discovery of Igf2 as an 
imprinted gene, showed that it has a major role in fetal growth during gestation. Lastly, 
the maternally expressed gene H19 was discovered by Bartolomei, a few months after 
Igf2. It encodes for noncoding RNA [49].   
Noncoding RNA are highly important in regulating genomic imprinting. Many 
imprinting clusters contain noncoding RNA and protein coding genes which are 
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reciprocally expressed such as H19,Igf2, Igf2r/Air, Dlk/Gtl2, and Kcnq1/Kcnq1ot1 [50–
52]. It is hypothesized that RNA may recruit epigenetic factors, such as PRC2, that 
regulate the imprinted expression of the coding genes [53,54]. 
Imprinted control regions (ICR) are usually 1Mb clusters that contain both 
maternal and paternal imprinted genes and at least one non coding RNA [46]. The 
regulation of imprinted genes is due to DNA methylation. The CpG islands found at the 
promoters of imprinted genes are mostly methylated and repressed whereas the 
expressed gene is unmethylated. These regions are called differentially methylated 
regions (DMR) [46]. 
DNA methylation is best studied as a regulatory mechanism in genes regulated 
by genomic imprinting [55]. Genomic imprinting occurs when specific genes are 
expressed by only one parent’s allele. For example, if a gene is maternally imprinted, the 
maternal allele has less expression while the paternal allele is predominantly expressed 
(Figure 9).  As shown by McGrath, both parental genomes are required for the 
development of a fetus [45]. Genomic imprinting is controlled by DNA and histone 
methylation [55]. 
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Figure 9. Genomic Imprinting. Maternal allele expression of H19 with the H19 paternal allele imprinted. 
The Igf2 paternal allele is expressed while the maternal allele of Igf2 is imprinted.[56] 
 
 
There are two critical stages of DNA demethylation in mammalian reproduction. 
In the first stage, primordial germ cells undergo global demethylation, which includes 
the erasure of parental imprinted methylation [57]. Once the gametocyte is fully 
developed and mature, de novo methylation is already reestablished in a parent of origin 
specific pattern (Figure 10). The second stage of demethylation (reprogramming) occurs 
only with the non-imprinted genes and is local only up to the blastocyst. There is an 
active paternal demethylation of somatic genes in the pronucleus while a passive 
maternal demethylation of somatic genes in the preimplantation embryo [58] (Figure 
10). The genome resumes de novo remethylation by DNA methyltransferase after 
implantation [59]. The imprinted genes retain their methylation marks during this stage 
of the reprogramming period, which allows for monoallelic expression [60] (Figure 10).  
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Figure 10. Methylation Reprogramming.  Paternal methylation marks are indicated with the blue line, 
maternal methylation marks are indicated with the green marks, while the red line indicates the 
methylation of genes in the imprinting control regions. The orange lightning bolt indicates the most places 
in reprogramming that epimutation can occur.[61] 
 
 
1.3.2 Faulty Expression of Imprinted Genes 
Disruptions in imprinted genes expression are a method to detect environmental 
perturbations on the epigenome. With only one allele expressed, depending on the 
parental origin, it is easier to look at the environmental effects on the gene of the 
gametes through inheritance of imprinted patterns of gene expression [62]. 
Environmental factors, such alcohol and BPA, may disrupt regulation or imprinting. 
Assisted reproductive technologies (ART) may also disrupt imprinting in ART, the 
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culture media may also influence imprinted gene expression of H19. When embryos 
were cultured in Whitten’s media until the blastocyst stage, the normally silent paternal 
allele of H19 was expressed [63]. H19 and Snrpn also showed biallelic expression in the 
placenta, but not in the embryo. The embryo exhibited reduced methylation at the ICR of 
Snrpn and H19 [64].  Haycock and Ramsay demonstrated that, when pregnant dams 
were exposed to alcohol, methylation decreased in the paternal alleles in the placenta 
[65].  Dams exposed to BPA in the late stages of oocyte development deregulated 
imprinting in the placenta, most notably in Snrpn, Ube3a, Igf2, Kcnq1ot1, Cdkn1c, and 
Ascl2. Additionally, a genome-wide methylation analysis found the placenta had 
reduced methylation compared to the embryo [66].   
When these imprinted genes are disturbed, the results can be devastating. 
Changes in imprinting are responsible for Beckwith-Wiedemann syndrome, Prader-Willi 
syndrome, Angelman syndrome, and Silver-Russell syndrome.    
Angelman syndrome (AS) is named after Harry Angelman.  He identified the 
following characteristics in AS children:  mental retardation, speech impairment, ataxia, 
and microcephaly (Figure 11a). AS is thought to be caused by a deletion in chromosome 
15 where the maternal gene is usually expressed. One in every 15,000 to 20,000 children 
are diagnosed with Angelman syndrome [67].   
In the same region that affects AS, there is another imprinted gene that is 
maternally imprinted with the paternal allele being expressed. When the paternal 
expression is lost, it can lead to Prader-Willi syndrome (PWS). Langdon-Down who first 
described Down syndrome also described the characteristics of Prader-Willi syndrome 
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before Prader, Labhart, and Willi [68]. PWS is characterized by childhood obesity, lack 
of muscle strength, and cognitive impairment[67,69] (Figure 11b). The estimated cases 
of PWS in the world are 1 in 10,000-30,000 [70]. 
Bruce Beckwith and Hans-Rudolf Wiedemann discovered a new syndrome called 
exomphalos-macroglossia-gigantism syndrome (EMG) in 1963 that later became known 
as  Beckwith-Wiedemann syndrome (BWS) [71]. BWS children have clinical features of 
microcephaly, macroglossia, neonatal hypoglycemia, and exomphalos [46] (Figure 11c). 
The most frequent cause of Beckwith-Wiedemann Syndrome is the  loss of the maternal 
allele at region 11p15.5 resulting in a double expression of the paternal allele[72]. This 
is also called uniparental paternal disomy [73]. It is estimated that BWS affects 1 in 
14,000 children[72]. 
In 1969, Tanner and Ham are responsible for terms “Silver dwarf” and “Russell 
dwarf”  that are known collectively now as  Silver–Russell syndrome (SRS) [74]. SRS 
children have characteristics of intrauterine and postnatal growth retardation, triangular 
face and learning disabilities[46] (Figure 11d). The most common cause of SRS  is 
associated with  H19 and IGF2  in the imprinting region of 11p15 [75].  One in 75,000 - 
100,000 people are affected with SRS [76].  
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Figure 11. Common Imprinting Disorders. (a) Angelman Syndrome, (b), Prader Willi-Syndrome, (c) 
Beckwith-Wiedemann Syndrome, and (d) Silver-Russell Syndrome. [77–80] 
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1.4 Spermatogenesis 
1.4.1 The Making of Sperm 
Spermatogenesis is the process of forming spermatids from undifferentiated male 
germ cells - spermatogonia - in the seminiferous tubules of the male testes. 
Spermatogenesis has three main phases: proliferation, meiosis, and differentiation 
(Figure 12). During the proliferation stage, spermatogonia proliferate to produce more 
spermatogonia. The meiotic stage occurs when the primary spermatocytes undergoing 
mitotic division to produce haploid secondary spermatocytes. This stage insures an 
increase in genetic diversity. The final stage, differentiation is when the spermatid 
undergoes morphological changes to become spermatozoa [81].  
 
 
 
Figure 12. Phases of Spermatogenesis. Three phases of spermatogenesis are proliferation, mitosis, and 
meiosis.[82] 
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Like all mammalian species, mice have a spermatogenesis cycle specific to their 
species. Their meiotic cycle begins in the fetus when the seminiferous tubules form, 
which contain Sertoli cells and germ cells. Meiosis begins at during the first week post 
birth, and the first spermatids are made by day 22-24. Complete sperm are formed in the 
mouse by day 28, but quantitatively not enough sperm for fertilization[83]. 
There are 12 stages and four cycles ending in 33 days to produce mouse 
spermatids in the seminiferous tubules (Figure 13). Each cycle takes 8.45 days and each 
cycle has 12 stages that occur in the seminiferous tubules. After 33 days, spermatid 
maturation occurs in epididymis[84]. 
The final product is a 65mm spermatozoa comprised in three sections: head, 
midpiece, and tail. The head is where the genetic material resides, a haploid nucleus and 
acrosome head resides, and midpiece is where the mitochondria reside. The tail is where 
the microtubules that constitute the flagellum reside, which enables the motility of the 
sperm[81].  
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Figure 13.  Mouse Spermatogenesis. The 12 stages involved in spermatogenesis to produce spermatozoa 
in the seminiferous epithelium.  [85] 
 
 
1.4.2 When Problems Arise in Spermatogenesis 
When spermatogenesis is disrupted or incomplete, it can lead to problems in 
fertility and the development of offspring. Factors that can influence spermatogenesis 
include radiation, folate, obesity, age and alcohol. 
Some men who have undergone chemotherapy or radiation can become infertile. 
The germinal epithelium is sensitive to radiation which can change the spermatogonia. 
The amount of  radiation can be as little as 0.2 Gray (unit of absorbed radiation)[86]. If 
the spermatogonia are damaged, the process of proliferation is halted during 
spermatogenesis. 
As men age, there is an inverse relationship with sperm morphology. Sperm 
morphology decreases 0.9% each year, totaling a 18% decrease in a male who is 50 
years of age in comparison to a 30-year-old man [87].  Both morphology and motility 
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change with age.  Occurrences of microcephalic heads and coiled tails increase as well 
with with age [88]. According to Auger,  there is a 0.6% decrease each year in motile 
sperm with a 12% decrease in motility in a 50 year old man in comparison to a 30 year 
old man [87]. 
In 2013, Lambrot  gave male mice a low folate diet [89].  The offspring sired by 
experimental males were born with more birth defects such as craniofacial and 
musculoskeletal malformations. A genome-wide DNA methylation analysis on the 
sperm found different methylation patterns on the genes associated with autism, 
schizophrenia, diabetes, and cancer. 
Most recently, Donkin profiled the epigenome of lean and obese men. The 
patterns of noncoding RNA abundance and DNA methylation were quite different, but 
the histone positioning was similar. His study found that men who were obese and had 
undergone surgically induced weight loss showed a drastic change in the DNA 
methylation in their sperm [90].  Ergo, there is a correlation between environmental 
factors present in the father’s lifestyle that will affect the gene expression of the sperm. 
Additionally, male consumption of ethanol can lead to decreased semen volume, 
sperm count, motility, and abnormal sperm morphologically [91]. Finally, male mice 
were chronically exposed to differing amounts of ethanol, and those exposed the most to 
ethanol had the most decrease in sperm motility [92]. Furthermore, sperm from alcoholic 
mice showed not only a decrease in quality, but in fertilization capability as well [93]. 
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1.5 Parental Contributions to Development 
1.5.1 Parental Nutrition 
Couples planning their pregnancy are encouraged to lead healthy lifestyles 
through diet and exercise. During a prenatal visit, obstetricians will ask questions about 
the women's smoking, alcohol, medication, and family history. The father, typically, is 
rarely asked about his lifestyle except for family history. As shown below, recent 
research suggests the father’s lifestyle is an important factor in prenatal development and 
indicates the father’s inheritance is more than DNA. 
For example, if paternal grandfathers experienced famine, then their 
grandchildren were more likely to be obese [94]. Over thirty years ago, David Barker 
found a correlation between low birth weights and ischemic heart disease, and poor 
nutrition and insufficient oxygen during gestation [95,96]. These effects are now called 
"Barker's Hypothesis", and encompasses the study of developmental origins of health 
and disease. 
Another recent example shows that offspring sired from males fed a low protein 
high fat diet  had an increased expression levels of hepatic genes associated with lipid 
and biosynthesis [97]. In addition, fathers exposed to a high-fat diet had female offspring 
with elevated b-cell dysfunction, which is a major precursor to type 2 diabetes [98]. 
Fathers who exercised regularly had offspring with altered levels of energy expenditure 
and insulin resistances [99].   
Stress is another environmental factor that can cause epigenetic triggers. Male 
mice exposed to stress showed an increase expression with nine microRNAs. The 
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increase is linked with a reduction in the hypothalamic-pituitary-adrenal (HPA) axis 
stress responsivity. Their offspring had a decrease in stress responsivity and increased 
expression of glucocorticoid response genes [100]. 
Gene regulation can also be influenced by drug usage.  When male rats self-
administered cocaine, the male offspring had an increase in mRNA and protein 
expression of corticotrophin-releasing factor receptor 2 in the hippocampus. Their male 
offspring showed an increase in anxious behavior [101]. Another trial by Lee in 2009, 
showed that there was an increase in acute lymphoblastic leukemia in offspring whose 
fathers smoked at home due to the absence of a haplotype of  cytochrome P450, family 
1, subfamily A, polypeptide 1 (CYP1A1) [102]. 
1.5.2 A More Focused Look on Fetal Alcohol Syndrome 
Alcohol, a known teratogen, is found to affect the development of the fetus by 
altering gene expression [103]. It is also known to disrupt the regulation of  DNA 
methylation in the genome [104]. 
Fetal Alcohol Syndrome (FAS) is a common disorder affecting six to nine per 
1,000 live births [105]. The effects of FAS are devastating, characterized by growth and 
mental retardation, neural and craniofacial abnormalities, and decreased birth weight 
(Figure 14). Until recently, only the maternal contribution to FAS has been 
studied.  However, due to patterns of imprinted gene expression, paternally inherited 
genes are a major driver of placental development; therefore, the effects of paternal 
alcoholism must be studied in relation to the observed FAS growth phenotypes [59]. As 
discussed in the previous section, environmental factors present in a male’s lifestyle 
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influence spermatogenesis through epigenetic mechanisms, which in turn can cause 
congenital defects. Fetal Alcohol Syndrome may be one such effect. 
 
 
 
Figure 14. Fetal Alcohol Syndrome Characteristics. Low nasal bridge, ear abnormalities, smooth ridge 
between upper lip and nose, small jaw, thin upper lip, flat midface, short nose, small opening between 
eyelids,  and skin fold of the upper eyelid covering the inner corner of the eye.[106]  
 
 
Until recently, FAS was thought to be solely caused by maternal alcoholism. 
However, growing evidence suggests fathers may also contribute FAS. One in ten adults 
in the U.S. meet the criteria for alcohol dependence [107].  Of these, men are more likely 
to drink excessively during their young adulthood years (18-24) and have 12.5 binge 
drinking episodes per year, far exceeding women’s reported levels of 2.7 episodes per 
year [107,108]. According to the National Institute on Alcohol Abuse and Alcoholism a 
binge drinking episode is defined as the consumption of five or more drinks within a 
two-hour period, to exceed a blood alcohol content level of 80 mg/dL [109]. Due to this 
  27 
magnitude of paternal alcoholism, and prior evidence suggesting the influence of male 
lifestyles upon their offspring, the effects on reproduction must be examined. 
There has been little research on chronic exposure of alcohol of a father and the 
effects of offspring. Previous research has found children sired from alcoholic fathers 
have reduced birth weight, decreased cognitive ability, and increased hyperactivity 
[110–112].  Additionally, offspring of chronically exposed alcoholic mice exhibit 
hearing loss [92]. When male mice were exposed to alcohol, their offspring were shown 
to have decreased litter size, birth weight, and decreased cognitive ability [113–
115].  These observations have been shown in paternal mice that were drinking while 
mating as well as after withdrawal periods prior to mating [116]. 
The molecular effects of males chronically exposed to alcohol have has very 
little attention. One study observed the methylation of spermatozoa and cerebral cortices 
of offspring sired from male mice chronically exposed to ethanol. However, this study 
used Kumming (Km) mice that were given ethanol every 2 days for four weeks. 
Spermatids in male mice take 33 days to form (Subheading 1.4.1). Liang did not wait for 
the male mice to be exposed to alcohol for at least one cycle of spermatogenesis before 
mating with untreated females and failed to clear the unexposed premeiotic sperm. The 
methylation patterns of imprinted maternally expressed transcript non-protein coding 
(H19) and paternally expressed 3 (Peg3) in spermatozoa showed a significant decrease 
and increase respectively. Three CpG islands of Peg3 in the cerebral cortices had a 
significant increase that mimicked the CpG islands of Peg3 in the spermatozoa[92] Their 
result does not indicate a strong correlation of methylation between the spermatozoa and 
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cerebral cortex of Peg3. There are eleven CpG islands in PEG3 and only 27% of the 
CpG islands in the cerebral cortex mimicked the sperm CpG island methylation in Peg3. 
However, this study did indicate that exposure to alcohol alters methylation patterns in 
imprinted genes in spermatogonia and could give rise to developmental disorders such as 
FAS [92]. 
Given the body of presented evidence, there is likely to be a correlation between 
male alcohol consumption and congenital birth defects such as Fetal Alcohol Syndrome 
through an epigenetic mechanism. The hypothesis of this work is the offspring from 
males chronically exposed to alcohol will exhibit some of the characteristics of Fetal 
Alcohol Syndrome. Chronic male exposure to alcohol may have a role in FAS but to 
date this has not been rigorously investigated. We suspect that the offspring will have 
smaller fetal weights, placentas, gestational sacs, and longitudinal and sagittal 
lengths.  The sperm from the chronically exposed males will have a decreased motility, 
and the paternal genomic imprints will be altered. We have elected to focus our studies 
on several key imprinted genes, as these are the ones best supported by the literature, we 
have validated reagents to do so, and their misregulation often serves as a “canary in the 
coal mine” for other epigenetic abnormalities [117]. Further, Peg3 loss of imprinting 
influences placental growth but exhibits normal morphology, while Igf2 loss of 
imprinting is associated with errors in morphological patterning [55,118]. Thus these 
genes have well-characterized links to fetal and placental growth parameters, which we 
will be measuring. 
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CHAPTER II  
MATERIALS AND METHODS 
Experimental mice were maintained on a 12-hour light/dark cycle where ethanol 
was made available during the initial four hours of the dark cycle. This “drinking in the 
dark” paradigm is similar to the one first described by Rhodes et al., where ethanol was 
introduced early in the dark cycle by replacing the water bottles with a 10% ethanol 
solution. This model was selected due to its demonstrated ability to produce high blood 
ethanol concentrations, which are similar to those obtained in other models of chronic 
alcohol exposure, but without the stress of excessive mouse handling [119]. In our 
experiments, male mice,  B6(Cast7), were treated with 10% ethanol solution with 
0.066%(w/v) saccharin for 70 days, while the control male mice, B6(Cast7), were 
exposed to 0.066% (w/v) saccharin ad libitum [120].  C57BL/6J and B6(Cast7) mouse 
strains were chosen to easily observe allelic patterns and transcription. The B6(Cast7) on 
portions of chromosome 7 and 12 from Mus musculus castaneus (CAST has at least 30 
imprinted genes and 5 imprinting domains) [121]. These traits make examining maternal 
and paternal alleles easier. 
The experimental mice were initially treated with 5% ethanol solution for a week 
to introduce ethanol to them. After one week, the ethanol was increased to 10%. The 70 
day duration included 18 days of the formative growth phase within spermatogenesis 
[122]. There was one mating at day 35 to clear the preformed sperm with non-
experimental C57BL/6J dams for all male mice (experimental and control). Because the 
mice were exposed to ethanol for 70 days, and mated midway at day 35, this ensured all 
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post meiotic sperm was exposed to ethanol (Figure 15). All experiments done under 
AUP 2014-0087 and approved by Texas A&M University IACUC. 
 
 
Figure 15. Times Mice Were Bred. The vertical hash marks indicate when males were off ethanol for a 
single night for breedings. The maximum time off ethanol was 3 consecutive days (Not drawn to scale.)  
 
 
Four blood samples of 20µL were collected throughout the duration of ethanol 
exposure to measure their blood ethanol content from the lateral saphenous vein and 
measured with gas chromatography[120]. Using a Varian 3900 Gas Chromatograph with 
8400 Autosampler the ethanol(mg/dl) of each blood sample was taken. Twenty 
microliters of blood were dispensed into a vial with 200 µL of a solution of 70% 
perchloric acid and 100% n-propanol. The final concentration of the solution was 0.6 N 
perchloric acid and 4 mM n-propanol. The vial containing the blood and solution was 
kept at room temperature overnight and run the following day. 
After three successful matings that led to pregnancies, male mice were sacrificed 
with carbon dioxide and cervical dislocation. Human tubal fluid (HTF) media (Life 
Global Group, GMHT-100) was supplemented with 4mg/ml of BSA fraction V (Sigma 
Aldrich, Cat. No. A5611 or A9647) and 1µl/ml of Gentamicin (Gibco 15750-060) was 
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prepared three hours before males were sacrificed.  One dish was prepared (35 x 10 mm 
Petri) for each sample with 1 ml of HTF media and covered with mineral oil, the dish set 
in an incubator at 37°C in a 5% CO2, 5%O2, 90% N2 atmosphere. The remaining HTF 
medium was stored in the same incubator for three hours. 
The male mice were placed on their back and sprayed with 70% ethanol. A cut 
was made into the skin to expose the peritoneum and body cavity. The skin was pulled 
away to expose the testis and epididymis to locate the vas deferens. Connective tissue 
was dissected away from the vas deferens to remove as much of the fat and bloods 
vessels that surround it. A cut was made 0.5cm away from the epididymis, and the vas 
deferens was placed into a petri dish that contained warmed handling medium (PBS). 
The vas deferens was then placed into the petri dish containing the mouse fertilization 
media from the incubator.  Forceps were used to remove the sperm through the cut end 
and three or four holes were punctured into the epididymis to facilitate the release of 
sperm. The dish was then placed back into the incubator for thirty minutes. 
The concentrated sperm from the vas deferens and the whole epididymis were 
placed in a 5mL polystyrene round bottom tube (BD Falcon, Cat. No. 353058) at a 45° 
angle in the incubator for 1 hour. This facilitated the live sperm to swim up from the 
debris and dead sperm.  Then 1.5 ml were removed from the top of the round bottom 
tube and placed into 1.5 ml tube. Sperm were diluted to a 1:1 dilution factor with 
millipore water and counted using a hemacytometer. 
After 70 days of regular drinking, the male mice were mated with non-
experimental dams, C57BL/6J. The pregnant dams were sacrificed at E14.5 by CO2 and 
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cervical dislocation.  On E14.5, the maternal decidua was easily removed from the fetal 
interface and fetal tissues (placenta, brain, and liver) and measurements (dam, fetus, 
gestational sac, placental weights and longitudinal sagittal length) were taken. The 
placenta was easily removed from the fetus and cut into four equal parts. The liver was 
dissected out of the fetus, and the brain was cut into equal halves. The remaining fetal 
tissues were kept and used for sexing the fetus. The fetuses’ location in the uterine horn 
(left- L or right - R) was recorded. The tissues were dissected using standard dissections 
tools and the weights were obtained using a scale. The longitudinal and sagittal length 
was measured with calipers. 
RNA was isolated from placental tissue using the RNeasy Mini Plus Kit 
(Invitrogen, Cat. No. 74134) following the manufacturer's guidelines. The placental 
tissue DNA was extracted using DNeasy Blood and Tissue Kit (Qiagen, Cat. No. 69504) 
following the manufacturer’s guidelines. Both the RNA and DNA were stored at -80°C 
until further use. 
RNA sequencing was performed on an Illumina HiSeq 2500 from the MIT 
Whitehead Institute to examine the individual transcriptome of eight samples. The eight 
samples were comprised of two females and two males from ethanol exposed sires and 
two females and two males sired from control males. 
Three samples from the control mice sperm and three samples from ethanol 
exposed mice sperm used to determine the methylation of the CpG sites in the genome. 
The sperm DNA was sent to Epigentek for enhanced methyl-seq.  The samples were 
subjected to enzymatic digestion (MSP1 + TaqI), library preparation, bisulfite 
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conversion, Bioanalyzer QC, KAPA library quantification, multiplex NGS on an 
Illumina HiSeq2500 and advanced data analysis. 
Gene expression was done on Kcnq1ot1, H19, Igf2r, Kcnq1, Ascl2, Gtl2, Peg3, 
and Kcnq1 that are imprinted genes in the placenta and have been associated with 
placental developmental defects [55,118] . Three of which are paternally expressed 
(Kcnq1ot1, Igf2, and Peg3) and five that are maternally expressed (Igf2r, H19, Ascl2, 
Gtl2, and Kcnq1). The isolated RNA was used for reverse transcription to acquire cDNA 
(Table 1). A polymerase chain reaction (Table 2&3) was then used to amplify the DNA. 
The annealing temperature was dependent on the gene (Table 3). A DNA digest was 
then done using restriction endonucleases (Table 3) followed by gel electrophoresis on a 
1% gel with 4µl of gel red and 1µl of 1000kb ladder at 90V for 180 minutes. 
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Step Instructions Product 
Part A: DNAse 
Treatment 
Treat 1ug of RNA with DNAse to eliminate genomic 
DNA concentration.  
• Combine 1µg of RNA and water to a total 
volume of 8 µl.  
• Combine 1µg of RNA and water to a total 
volume of 8 µl.  
• Add 1ul of DNAse buffer 
• Add 1ul of DNAse 
• Mix gently and keep at room temperature for 
15 minutes then add 1µl of Stop Solution. 
Sigma DNAse 
(AMP-D1)  
Part B: Reverse 
Transcription I 
Split the DNAse treated RNA into 4 groups: 3 positive 
and 1 negative reverse transcription 
• 1µl of 10 mM dNTP/sample 
• 1µl Random Hexamers/sample 
• 2.75 µl of the DNAse treated RNA 
• 8.25ul water 
• Incubate at 70°C for 10 minutes 
 
Invitrogen,18427-
013 
Invitrogen, 
48190011 
 
Part C: Reverse 
Transcription II 
Positive and Negative reverse transcription 
• 2µl 0.1M DTT per sample 
• 4µl 5x 1st Strand Superscript II Buffer 
• 1µl of Superscript II (Positive) 
• 1µl of water (Negative) 
Add 7 µl into each reverse transcription reactions 
 
Invitrogen,18064-
071 
 
Part D: Program 
Reverse Transcription Program 
• 42°C 50 Minutes 
• 45°C 10 Minutes 
• 50°C 10 Minutes 
• 55°C 10 Minutes 
• 70°C 5 Minutes 
• 4°C Hold  
 
Table 1.  Reverse Transcription Protocol. Reverse transcription steps and catalog numbers.  
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Reagent Amount Product 
Platinum Taq Polymerase 0.1µl Invitrogen, 10966034 
10X PCR Buffer, Minus Mg 2.5µl Invitrogen, Y02028 
50 mM MgCl2 0.75µl Invitrogen, Y02016 
10 mM dNTP 0.5µl Promega, U1515 
10µM Primers 0.5µl  
1:100 DNA 5µl  
Ultra-Pure Water 14.65µl  
 
Table 2. Polymerase Chain Reaction Protocol. PCR steps and catalog numbers.  
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Gene 
Primer 
Sequence 
Forward 
(5’to 3’) 
Primer 
Sequence 
Reverse 
(5’to 3’) 
Annealing 
Temperature 
(°C) 
New England 
Biolabs 
Restriction 
Endonuclease 
New 
England 
Biolabs 
Catalog 
Number 
H19 
TGATGGAG
AGGACAGA
AGGGC 
CTTGATTCA
GAACGAGAC
GGACT 
60.0 Cac8I R0579S 
IGF2 
ATCTGTGAC
CTCCTCTTG
AGCAG 
GGGTTGTTT
AGAGCCAAT
CAA 
55.0 MluCI  R0538S 
Ascl2 
TGAGCATCC
CACCCCCCT
A 
CCAAACATC
AGCGTCAGT
ATAG 
61.0 SfcI R0561S 
Kcnq1 
CATCGGTGC
CCGTCTGAA
C 
TGCTGGGTA
GGAAGAGCT
CAG 
58.8 NlaIII R0187S 
Kcnq10t1 
ATTGGGAA
CTTGGGGTG
GAA 
GGCACACGG
TATGAGAAA
AGATT 
56.5 StuI R0187S 
Peg3 
AAGGCTCT
GGTTGACA
GTCGTG 
TTCTCCTTGG
TCTCACGGG
C 
60.0 HpyCH4III R0618S 
IGF2r 
TGGAGACC
TCACCCTCA
TCTATTC 
GCACACAGC
AAGCATCTT
CAG 
60.0 TaqαI R0149S 
Gtl2 
CCAAAGCC
ATCATCTGG
AATC 
CAGCCCTGT
GAGGTAGGA
AC 
53.4 SfcI R0561S 
 
Table 3. Annealing Temperatures. 
 
 
 
Each fetus was sexed by using the DNeasy Blood and Tissue Kit previously 
mentioned. A PCR using Zfy and Xist primers (Table 4) with a 58°C annealing 
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temperature was run on the DNA that was extracted. The PCR product was then run on a 
1% agarose gel using the same parameters previously. Xist was used for a positive 
control to detect if DNA was present and Zfy was used to determine the sex. If a band 
appeared on the gel for Zfy, this indicated the fetus was a male. If there was no band, 
this indicated a female. 
 
 
Gene 
Primer 
Sequence 
Forward 
(5’to 3’) 
Primer 
Sequence 
Reverse 
(5’to 3’) 
Annealing 
Temperature 
(°C) 
Zfy AAGATAAGCTTACAT AATCACATGGA 
CCTATGAAATCCTTG 
CTGCACATGT 58.0 
Xist TTGCGGGATTCGCCT TGAT 
TGAGCAGCCCTTAAA 
GCCAC 58.0 
 
Table 4. Sex Determination. Primer sequences and annealing temperatures. 
 
By using an unpaired t-test, growth parameters, parental weights, and fluid 
consumption were tested using GraphPad Prism software. The RNA sequence of single 
nucleotide polymorphisms and the ratio of males versus females in the two treatment 
groups were analyzed with a Fisher’s Exact test on the GraphPad Prism software. The 
gene expression from the RNA sequencing data was analyzed with Cuffmerge and 
Cuffdiff, R statistical software, and Ingenuity Pathway Analysis. 
To test if there was an interaction between independent variables and dependent 
variables an ANOVA analysis was performed. There was no interaction between fetal 
weight compared to the sire’s weight (p>0.05) nor compared to the dam’s weight 
  38 
(p>0.05). We did not observe an interaction between the dam’s weight and litter size nor 
litter size and fetal weight (p>0.05). 
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CHAPTER III  
RESULTS 
3.1 Model of Male Alcohol Exposure 
To examine the impact of prenatal alcohol exposure on parental patterns of 
inheritance, two strains of mice carrying distinct single nucleotide polymorphisms were 
utilized. This allowed us to track allelic patterns of DNA methylation and gene 
transcription. The B6(Cast7) strain of mice [121] possess portions of a Mus musculus 
castaneus (CAST) chromosome 7 and 12 (where at least 5 imprinting domains and more 
than 30 imprinted genes reside) bred onto a C57BL/6J (B6) background. When using F1 
hybrid crosses between the B6(CAST7) strain and a C57BL/6J strain, we can distinguish 
maternal and paternal alleles using CAST and C57BL/6J polymorphisms that we have 
identified by either by primary sequence or database analysis.  These polymorphisms 
allow the identification of parental alleles through either primary sequence analysis or 
restriction digest based assays (i.e. one parental allele is susceptible to digestion while 
the other is not). These strains of mice are both from a C57BL/6J strain background 
which is susceptible to alcohol-induced teratogenesis. 
To investigate the impact of alcohol exposure on the male-inherited 
developmental program, an established mouse model of chronic, low-dose exposure was 
employed [120] Here, postnatal day 90, B6(Cast7) adult males were provided limited 
access to alcohol during a four hour window immediately after their sleep cycle [120]. 
Males were maintained on a 12-hour light/dark cycle (19:00-7:00) and provided access 
to either a solution of 10% (w⁄v) alcohol and 0.066% (w⁄v) saccharin (experimental) or 
  40 
0.066% (w⁄v) saccharin alone (control) for four hours a day. During the 70-day treatment 
period, the average fluid consumption normalized to body weight was not significantly 
different between the two treatment groups (Figure 16, p= 0.0937). 
 
 
 
 
Figure 16. Fluid Consumption Relative to Body Weight. Water intake for the control mice versus 
ethanol solution intake normalized to body weight. There was no significant difference in two treatment 
groups. Unpaired t-test p=0.0937. 
 
 
Further, over the experimental time course, an equivalent pattern of consumption 
was observed between both treatment groups (Figure 17, experimental p=0.2079 control 
p=0.3888). Based on previous reports, the expected blood ethanol content (BEC) are 
estimated to be 200 mg/dL [120]. For reference, the estimated BEC exceeds the legal 
limit in the U.S. of 80 mg/dL while driving. A BEC of 150 mg/dL can induce symptoms 
including a severe loss of muscle control, vomiting, and a major loss of balance in 
humans [123]. 
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Figure 17. Fluid Consumption per Kilogram Bodyweight Over Time. The grams of ethanol and 10% 
of water consumed over an 80-day period with nine time points. Linear Regression was used for statistical 
analysis.  
 
 
Given the known association between excessive weight gain and altered 
epigenetic programming in sperm [90] we first wanted to examine if alcohol 
consumption was associated with changes in body mass. No significant differences in 
the weight or body condition of the experimental males were observed for the duration 
of treatment (Figure 18, p=0.5156).   
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Figure 18. Sire Weight. There was no significant difference between the sires’ weight (experimental sire 
n=10 control sire n=8). An unpaired t test was used for the statistical analysis. 
 
 
Once consistent patterns of drinking had been established, males were 
maintained on this protocol for a period of 70 days, which corresponds to the length of 
approximately two complete spermatogenic cycles, and ensures that both pre-meiotic 
and postmeiotic sperm were exposed to alcohol [122,124]. To clear mature, pre-existing 
sperm formed prior to Alcohol exposure, males were bred to non-experimental dams 35 
days after consistent drinking had been established. Once the 70-day milestone had been 
surpassed, males were mated to unexposed dams. No differences in the weights of 
experimental or control dams were observed (Figure 19, p=0.5361).  
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Figure 19. Dam Weight. There was no significant difference between the dams’ weight (experimental 
dam n= 22 control dam n=16). An unpaired t test was used for the statistical analysis 
 
3.2 Alterations in Fetal Growth Parameters Arising as a Consequence of 
Preconception Male Alcohol Exposure 
After confirmed matings (presence of a vaginal plug), dams were separated, and 
fetuses collected at day 14.5 of gestation. The GD14.5-time point was selected due to 
our technical experience reliably excising the fetal component of the placenta away from 
maternal tissues, in order to avoid contaminating maternal cells and accurately assess 
placental patterns of gene expression [125]. During this dissection, the uterus was 
removed, and the maternal decidua separated from the fetal interface. Subsequently, the 
length of the fetus and weight of the gestational sac, placenta and fetus were recorded 
from 38 (control n=16, ethanol n = 22) litters with 260 pups examined (control n=113, 
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ethanol n=147). From this data, chronic male alcohol exposure was determined to be 
associated with a significant 4% reduction in the weight of the gestational sac (Figure 
20a, p=0.0159) and a 5% reduction in fetal weight (Figure 20b, p = 0.0217). These 
observations are similar to a previous study, which also identified reduced weight at 
postnatal days 35-42 in the offspring of alcohol-exposed males [126]. Further, this 
growth restriction is similar in magnitude to the one previously reported by Gundogan et 
al., examining the offspring of ethanol-exposed dams [127]. Fetal crown-rump length 
decreased by 3% (Figure 20c p=0.0015). There was no significant difference between 
the placental weight between the two groups (Figure 20d, p=0.2981). 
Fetal / placental weight ratios have often been considered as a crude proxy to 
measure placental efficiency [128,129]. When we derived a ratio of fetal weight relative 
to placental weight, an 8% decrease in the relative size of the placenta in the offspring 
sired by alcohol-exposed males was observed (Figure 20e, p=0.0101). These results are 
consistent with those reported in animal studies examining assisted reproductive 
technologies [130]; while diametrically opposite to the observed impacts of maternal 
diabetes / obesity on fetal-placental growth [129,131].  
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Figure 20. Fetal Parameters. Gestational sac weight (b, control n=97, ethanol n=106), fetal (a, control 
n=112, ethanol n=135) and longitudinal length (c, control n=110, ethanol n=144) of the fetus were all 
significantly different from the control.  There was no significant difference of the placental weight 
between the two treatment groups (d, control n=114, ethanol n=147); however, there is a significant 
difference in placental efficiency (e, control n=110, ethanol n=135). An unpaired t-test was used for 
statistical analysis.  
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The sex of the fetus may also be an important factor influencing the observed 
differences. Therefore, we stratified our data based on fetal sex, which was determined 
using PCR. We first examined our dataset to determine if preconception alcohol 
exposure was associated with a difference in fetal sex. No significant difference in fetal 
sex was observed between the treatment groups (Figure 21, p=0.3756).  
 
 
 
Figure 21. Ratio of Sexes. There was no significant difference between the number of females and males 
in each treatment group. (control females n=62 control males n=50, ethanol females n=68 ethanol males 
n=67) Fisher’s Exact test was used for statistical analysis.  
 
 
We next sought to determine if fetal sex was a significant modifier of the 
observed alterations in fetal growth. There was a sex-specific difference in the weight of 
the gestational sac observed within the experimental treatment group with a 7% decrease 
in gestational sac in female offspring (Figure 22b, p=0.0095). However, when 
comparisons were made between treatment groups, the gestational sac of male offspring 
was not significant from sires in the alcohol treatment group compared to the offspring 
of sires receiving control treatments. Although, the gestational sac of female offspring 
sired by alcohol-exposed males was decreased by 6% compared to the female offspring 
of control males (Figure 22d, p =0.0068).  
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Figure 22. Gestational Sac Weight. The weight of the gestational sac was significantly different within 
the sexes of the experimental treatment groups, but not within the control group. However, when 
comparisons were made between treatment groups, a significant reduction in gestational sac weight was 
observed for female offspring, but not for male offspring. (Experimental gestational sac weight: female 
n=50, male n=51, control gestational sac weight: female n=50 male n=44). An unpaired t test was used for 
the statistical analysis. 
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When comparisons were made between the fetal weights of male and female 
offspring, we observed dramatic sex specific effects in the offspring of alcohol-exposed 
males. For example, no significant differences in fetal weights were observed between 
male and female offspring within the control treatment; however female fetal weight was 
10% lower than male weight in the offspring of the alcohol treatment group (Figure 23a-
b, p=0.2671, p=0.0020 respectively). These results indicate that female offspring were 
more profoundly impacted by preconception alcohol exposure than male offspring.   
 
 
 
Figure 23. Fetal Weight Within Treatment Groups. The experimental treatment had a significant effect 
on female offspring in comparison to the male offspring while there was no significant difference in fetal 
weight in the control treatment. (Experimental fetal weight: female weight n=65 male weight n=67, 
control fetal weight: female weight n=62 male weight n=50). An unpaired t test was used for the statistical 
analysis. 
 
 
Indeed, when sex-specific comparisons were made between experimental 
treatments, this is what we observed. Whereas no differences in fetal weights emerged 
amongst male offspring, females derived from alcohol-exposed males exhibited an 8% 
Fe
ma
les
Ma
les
 
0.20
0.22
0.24
0.26
0.28
G
ra
m
s
Control Sex Weight
p=0.2671
a
Fe
ma
les
Ma
les
 
0.20
0.22
0.24
0.26
0.28
G
ra
m
s
Exerperimental Sex Weight
p=
**
0.0020
b
  49 
decrease in fetal weight relative to those sired by control males (Figure 24a-b, p=0.4096, 
p=0.0039).  
 
 
 
Figure 24. Fetal Weight.  There was no significance in the weight in male offspring between the alcohol 
and control treatment groups; however, there was a significant decrease in female weight in the offspring 
sired by ethanol exposed males. (Experimental fetal: female weight n=68 male weight n=67, control fetal: 
female weight n=62 male weight n=50). An unpaired t test was used for the statistical analysis. 
 
 
There was a sex-specific differences in crown rump-length within the 
experimental group, but not within the control group or between the sexes of the 
treatment groups (Figure 25a-b, p=0.9053, p=0.0133 respectively). The females sired 
from experimental males had a 3% significant decrease in comparison to males sired 
from experimental males (Figure 25b, p=0.0133).  
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Figure 25. Longitudinal Fetal Length. There was a significant difference in fetal length within the 
treatment group, but not within the control treatment group. Nor was there a significant different with the 
sexes between the treatments groups. (Experimental fetal length: female n=77 male n=73, control fetal 
length: female n=60 male n=61). An unpaired t test was used for the statistical analysis. 
 
 
There was no significant difference in the placenta weight between or within 
each treatment group (Figure 26, p>0.05).  
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Figure 26: Placental Weight: There was no significant difference in the experimental or control sex 
weights nor in the sex between the two treatment groups. (Experimental: female n=79, male n=57, control: 
female n=73 male n=48). An unpaired t test was used for the statistical analysis. 
 
 
When we examined placental efficiency for sex-specific effects, we did observe a 
significant difference (Figure 27b, p=0.0038). The placental efficiency of the female 
offspring of alcohol exposed sires were significantly 12% smaller than either the male 
offspring within the alcohol treatment group and compared to females sired by control 
males with a 14% decrease. (Figure 27a, d, p=0.0038, p=0.0001).  
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Figure 27. Placental Efficiency. There was no significant difference in control placental efficiency nor 
the male offspring compared to the two treatment groups. However, there was a significant difference 
within the experimental group and between the female offspring between the two treatment groups. 
(Experimental: female n=66, male n=69, control ratio: female n=61 male n=49). An unpaired t test was 
used for the statistical analysis. 
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3.3 Altered Epigenetic Inheritance in a Model of Preconception Male Alcohol 
Exposure 
To establish if chronic alcohol exposure could influence the male-inherited 
epigenetic program, and be linked to the observed growth restriction, we next examined 
the DNA methylation profiles of paternal sperm. After a minimum of three matings, 
breeder males were sacrificed, and sperm collected using a modified swim-up procedure 
[132] No significant difference in sperm concentration was observed between the 
treatment groups (Figure 28a, p=0.2069). There was also no significant difference in the 
quantity of living sperm between treatments (Figure 27b, 0.6261).   
Figure 28. Sperm Analysis. Concentration of Sperm and percentage of live sperm compared to dead 
sperm. (Experimental n=4, control group n=3). Unpaired t-test was used for statistical analysis.  
After isolation of sperm, the DNA methylation profiles of three control and three 
experimental males were independently examined using bisulphite mutagenesis and 
second-generation deep sequencing [133,134]. The Methyl-Sequencing technique we 
employed queried the methylation status of 7-8 million unique CpG sites, 
Co
ntr
ol
Ex
pe
rim
en
tal
0
5
10
15
20
Concentration of Sperm 
m
ill
io
ns
/m
L
a
p=0.2069
Control Experimental
0
20
40
60
80
%
p= 0.6261
b
Percentage of LIve Sperm
54 
Figure 29. Percentage of Methylation at Promoter Regions. The percentage of methylation in the 
promoter regions H19, Ascl, and Igf2 was not statistically significant. Unpaired t-test was used for 
statistical analysis.   
which covers virtually all CpG islands, gene promoters, genetic regulatory 
elements, gene bodies, and repetitive DNA sequences within the mouse genome. 
For statistical comparison, the methylation data was broken down into promoter 
region, base pair, and tiling (1000bp) comparisons. In comparisons of the promoter 
regions, no differences in DNA methylation were observed for H19, Ascl2, or Igf2 
(Figure 29, p>0.05).  
Using base pair comparisons, no differences were observed within the regulatory 
regions of Peg3, or 15 locations within the regulatory region of Igf2r (Figure 
29, p>0.05).
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Figure 30. Percentage of Methylation at Base Pairs. The 15 different base pairs that were identified in 
Igf2r and one base pair from Peg3 had no significant percentage in methylation. Unpaired t-test p>0.05. 
Co
ntr
ol
Ex
pe
rim
en
tal
0
50
100
%
 M
et
hy
la
tio
n 
Igf2r
Chr. 17
Base: 12,687,866 
Co
ntr
ol
Ex
pe
rim
en
tal
0
50
100
%
 M
et
hy
la
tio
n 
Igf2r
Chr. 17
Base: 12,688,018 
Co
ntr
ol
Ex
pe
rim
en
tal
0
50
100
%
 M
et
hy
la
tio
n 
Igf2r
Chr. 17
Base: 12,688,116
Co
ntr
ol
Ex
pe
rim
en
tal
0
50
100
%
 M
et
hy
la
tio
n 
Igf2r
Chr. 17
Base: 12,688,188 
Co
ntr
ol
Ex
pe
rim
en
tal
0
50
100
%
 M
et
hy
la
tio
n 
Igf2r
Chr. 17
Base: 12,683,733 
Co
ntr
ol
Ex
pe
rim
en
tal
0
50
100
%
 M
et
hy
la
tio
n 
Igf2r
Chr. 17
Base: 12,688,090
Co
ntr
ol
Ex
pe
rim
en
tal
0
50
100
%
 M
et
hy
la
tio
n 
Igf2r
Chr. 17
Base: 12,688,180 
Co
ntr
ol
Ex
pe
rim
en
tal
0
50
100
%
 M
et
hy
la
tio
n 
Igf2r
Chr. 17
Base: 12,688,204 
  56 
 
Figure 30. Continued. 
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Figure 31. Percentage of Methylation Tiling (1000bp). None of the candidate genes were significantly 
different in the percentage of methylation. Unpaired t-test p>0.05. 
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Figure 31. Continued. 
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Figure 31. Continued. 
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Figure 31. Continued. 
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Figure 31. Continued. 
 
Using tiling comparisons where the genome is broken into 1000 bp segments, 
and statistical comparisons made between regions, none of the candidate genes exhibited 
any statistically significant changes (Figure 31, p>0.05).  
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We next sought to determine if we could detect any alterations in the expression 
of our candidate-imprinted genes. The fetal placenta plays a critical role in controlling 
maternal-fetal resource allocation and mediating fetal growth [135,136]. Given the 
observed alterations in growth parameters of the placenta, we began our examination 
with this tissue. We first isolated RNA from placental samples and conducted deep 
sequencing analyses of the individual transcriptomes. Four samples (two males and two 
females) were analyzed from each of the control and experimental treatment groups. 
Total RNA was purified using an RNeasy Mini kit (Qiagen), and samples sequenced on 
an Illumina HISEQ 2500 (paired-end 100 bp). RNA expression levels were analyzed 
with Cuffmerge and Cuffdiff, statistical analysis performed with R, and data analyzed 
using Ingenuity Pathway Analysis. 
From this dataset, we did not detect any significant changes in the expression of 
our candidate-imprinted genes (Figure 31, p>0.05). When we mined the sequencing data 
set for alterations in the representation of single nucleotide polymorphisms, we observed 
alterations in the abundance of the paternal allele of H19, which exhibited a significant 
decrease in transcripts derived from the paternal allele (Figure 32g, p<0.0001). In 
contrast, Cdkn1c exhibited a significant increase in the contribution of the normally 
silent paternal allele (Figure 32h, p=0.0436). We were able to follow two SNPs in the 
Peg3 and Igf2 genes, and one SNP in Gtl2 and Ascl2 genes (Figure 32, p>0.05)(Table 
5). However, none of these demonstrated any significant differences.  
 
 
  63 
 
Figure 32: Gene Expression of Candidate Genes: There were no significant differences in the 
expression of expression of our candidate-imprinted genes within the placental samples examined.  
Unpaired t-test p>0.05. 
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Figure 33: Analysis of Single Nucleotide Polymorphisms. SNPs within the transcripts of our candidate 
imprinted genes. The only significant alterations in observed SNPs were in H19(g, p<0.0001) and Cdkn1c 
(h, p=0.0426). Unpaired t-test.   
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Gene 
B6Cast7 C57BL/6J 
Base 
Number 
Base 
Number 
Control Experiment Control Experiment 
Peg3 (1) G 119 117 A 1469 1542 
Peg3 (2) T 2604 2844 G 131 130 
Igf2 (1) A 77 86 G 1043 1016 
Igf2 (2) G 2135 2178 C 320 316 
Ascl2 C 10 11 G 76 122 
Gtl2 C 12 14 A 85 96 
H19 C 1603 1262 T 20324 20342 
Cdkn1c C 87 126 A 3397 3696 
 
Table 5. SNPs. List of all the SNPs examined. Only H19 (p<0.000) and Cdkn1c (p=0.0436) were found 
to be significantly different. Fishers Exact Test.  
 
 
Previous studies employing an in utero model of prenatal alcohol exposure in rats 
have reported disruptions in the expression of the imprinted gene Dio3 [137]. In this 
study, they reported parent of origin differences in the expression of Dio3 within the 
frontal cortex and hippocampus. When we examined these same genes in our dataset, we 
observed an increase in expression in two imprinted genes from this cluster; Dio3 and 
Mirg (Figure 33, p=0.0017 and p=0.0277 respectively). Unfortunately, no SNPs could be 
identified to confirm parental contributions. Interestingly, alterations in the expression of 
these genes were dependent upon the sex of the fetus. Expression of Dio3 was 
significantly increased in the female offspring of alcohol exposed males, whereas the 
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male offspring were not different between experimental treatments (Figure 34B, 
p=0.001).  
 
 
 
Figure 34. Gene Expression of Dio3 and Mirg.  Dio3 and Mirg exhibited a significant increase within 
the placentas of offspring sired by alcohol-exposed males. Analyses were conducted using the statistical 
program Cuffdiff. 
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Figure 35. Sex-Specific Alterations in Gene Expression. The female offspring sired from experimental 
fathers exhibited a significant increase in the expression of Dio3, relative to male offspring. This increase 
in expression was also higher than those observed within the female offspring of control males. Analyses 
were conducted using the statistical program Cuffdiff.   
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Of the candidate imprinted genes examined, we have developed restriction 
digest-based assays to examine parental patterns of gene expression (Figure 36). For 
Gtl2, Peg3, H19, Igf2, Igf2r, Kcnq1, Kcnq1ot1, and Ascl2 we expanded our analyses to 
test 14 random placental samples with equal representation of males and females. The 
maternally imprinted genes are: Kcnq1ot1, Igf2, and Peg3, whereas paternally imprinted 
genes are: Igf2r, H19, Kcnq1, Ascl2, and Gtl2.  The only gene to exhibit biallelic 
expression was Kcnq1ot1 (Figure 356), which exhibited increased maternal expression 
in three placental samples derived from alcohol-exposed males (A352, A341L4, and 
A341R5). The remaining seven candidate genes did not exhibit any detectable 
alterations in the regulation of imprinted alleles.  
 
 
a 
Peg3 Gene Expression 
(C57BL/6J -260 bp; BL6(Cast7) - 148,76,16 bp) 
 
 
Figure 36. Restriction Digest Gene Expression. The samples in the above gene expression images are in 
the following order: A352R5, A349R4, C333R1, A340R2, C335L3, A341L4, A341R5, C342, C357, 
A356, C338R1, C344L2, C342L5, A348L6, C57BL/6J, L6(Cast7). The red circles (h) show some 
expression from the maternal allele in Kcnq1ot1. (A-alcohol male offspring, C- control male offspring, R- 
right uterine horn, L- left uterine horn, number indicates what dam they were from)  
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b 
Ascl2 Gene Expression 
(C57BL/6J 474 bp; BL6(Cast7) - 266 bp) 
 
c 
Kcnq1 Gene Expression 
(C57BL/6J - 97,76 bp; BL6(Cast7) - 113,76 bp) 
 
 
Figure 36. Continued 
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d 
Igf2r Gene Expression 
(C57BL/6J -388 bp; BL6(Cast7) - 210 bp) 
 
e 
Igf2 Gene Expression 
(C57BL/6J -163 bp; BL6(Cast7) - 224 bp) 
 
Figure 36. Continued 
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f  
H19 Gene Expression 
(C57BL/6J -173 bp; BL6(Cast7) - 235 bp) 
 
g 
Gtl2 Gene Expression 
(C57BL/6J -250,87 bp; BL6(Cast7) - 337 bp) 
 
Figure 36. Continued 
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h 
Kcnq1ot1 Gene Expression 
(C57BL/6J -814 bp; BL6(Cast7) - 601,213 bp) 
 
Figure 36. Continued 
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CHAPTER IV  
DISCUSSION AND CONCLUSION 
Epigenetics is the study of heritable changes produced from environmental 
factors. These factors include, but are not limited to, diet, exercise, stress and alcohol 
exposure. Epigenetics can alter the transcriptome through modifications leading to a 
difference in gene expression and influencing animal phenotype. By modifying the 
expression of chromatin, epigenetics is thought to alter which proteins are transcribed, 
ultimately dictating phenotypes. The difference between epigenetics and DNA is 
epigenetics is reversible and plastic, while DNA is non-reversible and static. 
One of the mechanisms through which the environment influences transcription 
is through DNA methylation. DNA methylation is the most commonly studied 
epigenetic mechanism, as well as the first discovered to influence gene expression 
[23].  As previously stated, “DNA methylation is the addition of a methyl group on the 
fifth carbon of a cytosine nucleotide, to form 5-methylcytosine.” These additions to the 
major grooves of DNA affect protein interaction significantly and influence how loose 
or tight the chromatin is regulating  transcription and subsequently affect  gene 
repression or activation [19,23]. Gene activation is associated with demethylated 
regions, whereas gene repression is associated with DNA methylation[26].  DNA 
methylation is commonly found on these short interspersed CpG islands through the 
genome[26]. 
DNA methyltransferases(DNMT) are responsible for regulating methylation. The 
family of DNMTs is comprised of DNMT1, DNMT2, DNMT3a, DNMT3b, and 
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DNMT3L. DNMT1 is known to maintain methylation within the genome, whereas 
DNMT3a and DNMT3b are known for de novo methylation [29,33], When these 
enzymes are misregulated, there can be catastrophic effects for the fetus, ranging from 
birth defects to death. While misregulation of DNA methylation is not always fatal, Rett 
Syndrome and cancer are associated with it [1,38–40]. 
DNA methylation is a well-studied factor in regulating genomic imprinting [55]. 
When genes are imprinted, one parental allele is relatively silent in comparison to the 
other allele. It is known that approximately 100 genes in mammals are imprinted [46].  It 
is easier to judge environmental effects by studying the disruptions of imprinted genes 
because only one allele is expressed [62]. Some environmental factors, such as alcohol, 
may disrupt imprinting. 
Spermatogenesis is the process through which sperm are produced that includes 
three main phases: proliferation, meiosis, and differentiation. In mice, there are twelve 
stages, and four cycles culminating after 33 days[84]. Radiation, obesity, age and 
alcohol all can alter spermatogenesis, which can influence the development of offspring 
and fertility. Specifically, these factors can lead to decreased sperm morphology and 
motility, decreased semen volume and count, infertility, and misregulation of DNA 
methylation in sperm [86,87,89,90,92]. 
As previously stated, grandparents who survived starvation saw grandchildren 
more predisposed to obesity[94]. Studies have shown that the diet of the father does 
impact their offspring such as a low protein high fat diet and the association to increased 
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hepatic gene expression and a high fat diet and the relationship to female offspring 
having a elevated precursor to type 2 diabetes [97,99]. 
Another environmental factor such as alcohol, a known teratogen, can  influence 
gene expression and misregulation of DNA methylation [103,104]. 
Fetal Alcohol Syndrome is very prevalent in society occurring with six to nine 
per 1000 live births [105] Maternal alcoholism has long been known to cause FAS, but 
much evidence exists to suggest that paternal alcoholism may also affect offspring. 
Given that paternal inherited genes are a major influence on the development of the 
placenta, it must be studied how the male consumption of alcohol affects offspring [59]. 
Through this study, we have shown that male mice chronically exposed to 
alcohol do influence fetal parameters. Four out of our five measurements had a 
significant difference in comparison to the control treatment. Gestational sac weight was 
not only significant when comparing weights between the two treatment groups 
(p=0.0159), but also the female offspring from the exposed male had a significant 7% 
reduction in weight in comparison to female offspring from the control group 
(p=0.0095). This indicates that there is a decrease in amniotic fluid in the ethanol treated 
offspring. In early gestation, the amnion plays a major role in the development of the 
fetus. Reducing the amnion could be associated with developmental disorders. 
The second parameter that was significant was fetal weight. The fetal weight 
between the two treatment groups was significant with a 5% weight reduction in the 
experimental group (p=0.0217). While investigating the degree to which the fetuses were 
affected, we discovered there was a sex specific significant reduction in fetal weight. In 
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comparison to the male offspring from exposed male sires, the female offspring were 
significantly reduced in weight (p=0.0020). This indicates that the female offspring was 
more affected than the males. Supporting that is that there was no significance between 
the male fetal weight between the two treatment groups(p=0.4096). The female weight 
was significant when comparing it between the two treatment groups (p=0.0039). 
We did find a significant difference the length of the fetuses between the two 
groups (p=0.0015), additionally there was sex specific significant difference within the 
experimental treatment group. There was a 3% significant reduction in female length in 
comparison to male length from the experimental treatment (p=0.0133).  In addition, the 
placental weight between and within the treatment groups, was not significant. When 
using an alternate way to measure the placenta relative to the fetal weight, there was a 
significant difference in the treatment groups (p=0.0101). The experimental offspring 
had an 8% decrease in placenta efficiency. This data demonstrates a decrease in placenta 
efficiency and a decrease in fetal weight in the offspring from exposed sires. This may 
imply the placenta failed to transfer adequate nutrients to the fetus [129].  As before, 
there were was significant differences with the sexes between treatment groups with the 
females having a 14% significant decrease in placental efficiency, as well as a 12% 
significant difference in females compared to males sired by exposed males.  
When observing the methylation patterns in the candidate genes in the sperm, 
none of the candidate regions examined a significant difference in percentage of 
methylation. The examination of gene expression through these genes as well showed no 
difference in expression between the treatment groups. However, when looking at other 
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imprinted genes in the same ICR, we did discover two genes that did have a differences 
in expression: Dio3 and Mirg (p=0.0017 and p=0.0277 respectively). Upon further 
examination of Dio3, the expression was sex specific. In the experimental treatment 
group, the expression of Dio3 in female offspring significantly increased (p=0.0001), 
and when comparing the females between the two treatment groups the females sired 
from exposed males were also significant (p=0.0007). 
Although we did not find changes in gene expression in our candidate genes, we 
did observe two significant single nucleotide polymorphisms in H19 and Cdkn1c 
(p<0.0001 and p=0.0436 respectively). In H19 we did observe a significant decrease in 
transcripts from the paternal allele, whereas in Cdkn1c we observe an increase in the 
paternal allele that is normally silent. Loss of imprinting in Cdkn1c has been previously 
associated with a decrease in fetal growth [138]. Through the misregulation of the 
normal expression of the paternal allele in H19 and Cdkn1c, it does give support to the 
hypothesis that preconception male alcohol exposure can disrupt the expression of 
imprinted genes. 
From the evidence shown, we conclude that paternal alcoholism is a significant 
contributor to characteristics of Fetal Alcohol Syndrome such as low birth weight. 
Popular culture predominantly focuses the anti-drinking message towards an expectant 
mother, but that message may have to be expanded to include fathers. Additionally, 
because of the impact alcohol has upon a developing fetus, the duration of sobriety 
couples must maintain may also extend before a conception. This particularly applies to  
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men as sperm is produced continuously in their adult life regenerating spermatozoan that 
can be effected months before fertilization from environmental factors such as alcohol.   
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